Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novocure Ltd Ord Sh
(NQ:
NVCR
)
21.99
-0.18 (-0.81%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022
July 05, 2022
Upgrades
Via
Benzinga
Novocure to Report Second Quarter 2022 Financial Results
July 01, 2022
From
Novocure
Via
Business Wire
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid...
Via
Benzinga
NovoCure: Q1 Earnings Insights
April 28, 2022
NovoCure (NASDAQ:NVCR) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Novocure's TTFields Show Improved Progression-Free, Overall Survival Over Matched-Control
March 25, 2022
Novocure Ltd (NASDAQ: NVCR)
Via
Benzinga
Where NovoCure Stands With Analysts
February 08, 2022
NovoCure (NASDAQ:NVCR) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer
June 21, 2022
From
Novocure
Via
Business Wire
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer
June 03, 2022
From
Novocure
Via
Business Wire
The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review
May 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Newly Diagnosed Glioblastoma
May 26, 2022
From
Novocure
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022
May 16, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
April 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Novocure Reports First Quarter 2022 Financial Results
April 28, 2022
From
Novocure
Via
Business Wire
Novocure Hosts Ceremonial Groundbreaking with New Hampshire Governor Chris Sununu
April 19, 2022
From
Novocure
Via
Business Wire
Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2022 Suggesting Broad Applicability of Tumor Treating Fields
April 08, 2022
From
Novocure
Via
Business Wire
Novocure to Report First Quarter 2022 Financial Results
April 01, 2022
From
Novocure
Via
Business Wire
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
March 24, 2022
From
Novocure
Via
Business Wire
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
March 23, 2022
From
Novocure
Via
Business Wire
Up On Bad News
March 22, 2022
Despite the plane crash in China, Boeing's stock is up today.
Via
Talk Markets
Lucky Day
March 21, 2022
Today Alleghany rose nearly 25% because it is being bought by Berkshire Hathaway, Warren Buffett's fund.
Via
Talk Markets
World Markets News For Friday
March 18, 2022
Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%.
Via
Talk Markets
Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technological Innovation
February 28, 2022
From
Novocure
Via
Business Wire
Novocure’s General Counsel Resigns After 10 Years of Service
February 24, 2022
From
Novocure
Via
Business Wire
Novocure Q4 Earnings Miss Street View, New Data Shows TTFields Initiates Downstream Anti-Tumor Response
February 24, 2022
A new study published in the Journal of Clinical Investigation (JCI) finds treatment with Novocure Ltd's (NASDAQ: NVCR) Tumor Treating Fields (TTFields) mediated...
Via
Benzinga
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response
February 24, 2022
From
Novocure
Via
Business Wire
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
February 24, 2022
From
Novocure
Via
Business Wire
Bionano Stock Looks to Have a Monster Comeback in Its Future
February 17, 2022
Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.
Via
InvestorPlace
Give peace a chance
February 15, 2022
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 09, 2022
Gainers Bone Biologics (NASDAQ:BBLG) shar...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.